公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2003 | Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells | Pan S.-L.; JIH-HWA GUH ; Huang Y.-W.; Chern J.-W.; Chou J.-Y.; Teng C.-M. | Journal of Urology | 27 | 25 | |
2013 | Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study | Huang Y.-W.; Wang T.-C.; Lin S.-C.; Chang H.-Y.; DING-SHINN CHEN ; Hu J.-T.; Yang S.-S.; JIA-HORNG KAO | Clinical Infectious Diseases | 81 | 75 | |
2014 | Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study | Huang Y.-W.; Yang S.-S.; Fu S.-C.; Wang T.-C.; Hsu C.-K.; DING-SHINN CHEN ; Hu J.-T.; JIA-HORNG KAO | Hepatology | 95 | 87 | |
2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: A nationwide cohort study | Fu S.-C.; Huang Y.-W.; Wang T.-C.; Hu J.-T.; DING-SHINN CHEN ; Yang S.-S. | Alimentary Pharmacology and Therapeutics | 39 | 38 | |
2002 | Inhibition of Ras-mediated cell proliferation by benzyloxybenzaldehyde | Pan S.-L.; JIH-HWA GUH ; Huang Y.-W.; Chang Y.-L.; Chang C.-Y.; Huang L.-J.; Kuo S.-C.; Teng C.-M. | Journal of biomedical science | 11 | 9 | |
2020 | Juvenile-onset pustular psoriasis: case series and literature review | Huang Y.-W.; TSEN-FANG TSAI | British Journal of Dermatology | 5 | 5 | |
2020 | Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma | Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; CHING-YU LIN ; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU ; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN ; Liang H.-J.; Lin S.-M.; MING-WHEI YU | Molecular Carcinogenesis | 9 | 6 | |
2020 | Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review | MENG-RUI LEE ; LIH-YU CHANG ; JEN-CHANG KO ; HAO-CHIEN WANG ; Huang Y.-W. | Journal of the Formosan Medical Association | 12 | 8 | |
2008 | Onion decreases the ovariectomy-induced osteopenia in young adult rats | Huang T.-H.; M?hlbauer R.C.; Tang C.-H.; Chen H.-I.; Chang G.-L.; Huang Y.-W.; Lai Y.-T.; Lin H.-S.; Yang W.-T.; RONG-SEN YANG | Bone | 30 | 23 | |
2015 | Outcome correlation of smear-positivity but culture-negativity during standard anti-tuberculosis treatment in Taiwan | Chao W.-C.; Huang Y.-W.; Yu M.-C.; Yang W.-T.; Lin C.-J.; Lee J.-J.; Huang R.-M.; Shieh C.-C.; Chien S.-T.; JUNG-YIEN CHIEN | BMC Infectious Diseases | 5 | 4 | |
2020 | Pharmacological Management of Pediatric Pustular Psoriasis | Huang Y.-W.; TSEN-FANG TSAI | Pediatric Drugs | 9 | 6 | |
1997 | Psychosocial impacts and coping strategies of women with stress urinary incontinence | Huang Y.-W.; HONG-JENG YU ; Lai M.-K.; Chen T.-M,; FON-JOU HSIEH ; Hwang S.-L. | Tzu Chi Medical Journal | 5 | ||
2018 | Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study | CHI-SHIN WU ; Wu K.-Y.; Lo Y.-R.; Huang Y.-W.; Tsai Y.-T.; Li Y.; Tsai H.-J. | Journal of Affective Disorders | 7 | 6 | |
2013 | Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy | Huang Y.-W.; Lin S.-C.; SHU-CHEN WEI ; Hu J.-T.; Chang H.-Y.; Huang S.-H.; DING-SHINN CHEN ; PEI-JER CHEN ; PING-NING HSU ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 44 | 37 | |
2019 | Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience | Huang Y.-W.; TSEN-FANG TSAI | Dermatology and Therapy | 19 | 16 | |
2012 | The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis | WAN-TING HUANG ; Huang W.-I.; Huang Y.-W.; Hsu C.-W.; Chuang J.-H. | Vaccine | 29 | ||
2020 | Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B | Huang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; SHIH-JER HSU ; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN | Hepatology International | 18 | 14 | |
2021 | Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy | Lin H.-H.; SHIH-JER HSU ; Lu S.-N.; Chuang W.-L.; Hsu C.-W.; Chien R.-N.; Yang S.-S.; Su W.-W.; Wu J.-C.; Lee T.-H.; Peng C.-Y.; Tseng K.-C.; Qin A.; Huang Y.-W.; PEI-JER CHEN | JGH Open | 12 | 12 | |
2020 | Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment | JANN-YUAN WANG ; SUI-YUAN CHANG ; Huang Y.-W.; SHAN-CHWEN CHANG | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease | 9 | 7 | |
2010 | Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B | TUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 78 | 73 |